Literature DB >> 32359225

Haematological Effects of Intermittent Pneumatic Compression for Deep Vein Thrombosis Prophylaxis.

Rhys J Morris1, C Heledd Roberts2.   

Abstract

Intermittent pneumatic compression (IPC) is a widely used and recommended method to prevent deep vein thrombosis. While the haemodynamic effects of IPC are well understood, the objective of this systematic review was to analyse the evidence for additional haematological changes. Forty-eight studies were identified where the haematological effects of IPC were measured. The many differences between the studies prevented meta-analysis, but there was a significant amount of evidence that global fibrinolytic activity was increased by IPC, and that levels of D-dimer and tissue factor pathway inhibitor in the blood also increased. There was less consistent evidence for changes in tissue plasminogen activator, plasminogen activator inhibitor and other fibrinolytic parameters. The evidence for changes in pro-coagulant factors and many measures of platelet activation was weak, but there was evidence for increases in prostacyclin. There is sufficient evidence to conclude that IPC does produce haematological changes, but not enough data to clarify the detail of those changes or to determine if it is mediated more by direct compression of the blood vessels, or by the flow changes. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32359225     DOI: 10.1055/s-0040-1710016

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  2 in total

1.  Hemodynamic analysis of intermittent pneumatic compression combined with hyperthermia after total hip arthroplasty: an experiment on male rabbits.

Authors:  Siping Zhang; Pengcheng Ma; Aikeremujiang Muheremu; Rongxin Sun; Hao Chai; Kan Jiang
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

2.  Effective prediction model for preventing postoperative deep vein thrombosis during bladder cancer treatment.

Authors:  Xing Liu; Abai Xu; Jingwen Huang; Haiyan Shen; Yazhen Liu
Journal:  J Int Med Res       Date:  2022-01       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.